Showing results (431-440 of 4,573) with videos related to
Sort By:
Pageof 458
Chemmedchem|December 17, 2008
Toward docking-based virtual screening for discovering antitubulin agents by targeting taxane and colchicine binding sitesLaurent SoulèreChemmedchem|January 22, 2009
Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivirBenoit Carbain, Patrick J Collins, Lori Callum, et al.Chemmedchem|January 20, 2009
Cytotoxicities and structure-activity relationships of natural and unnatural lamellarins toward cancer cell linesMontakarn Chittchang, Paratchata Batsomboon, Somsak Ruchirawat, et al.Chemmedchem|October 19, 2007
Hyrtiosal, from the marine sponge Hyrtios erectus, inhibits HIV-1 integrase binding to viral DNA by a new inhibitor binding siteLi Du, Liangliang Shen, Zhiguo Yu, et al.Chemmedchem|October 24, 2007
Molecules that target beta-amyloidCliff I Stains, Kalyani Mondal, Indraneel GhoshChemmedchem|August 19, 2007
Artesunate and dihydroartemisinin (DHA): unusual decomposition products formed under mild conditions and comments on the fitness of DHA as an antimalarial drugRichard K Haynes, Ho-Wai Chan, Chung-Man Lung, et al.Chemmedchem|August 19, 2007
Functional classification of protein kinase binding sites using CavbaseDaniel Kuhn, Nils Weskamp, Eyke Hüllermeier, et al.Chemmedchem|November 27, 2007
Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2Björn Degel, Peter Staib, Sebastian Rohrer, et al.Chemmedchem|November 21, 2007
Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purinesMónica Díaz-Gavilán, Ana Conejo-García, Olga Cruz-López, et al.Chemmedchem|February 14, 2007
Central nicotinic receptors: structure, function, ligands, and therapeutic potentialM Novella Romanelli, Paola Gratteri, Luca Guandalini, et al.Pageof 458